EPR-Technologies announces new approach to emergency care when CPR fails
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.
Dr. Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
The Ayushman Bharat Digital Mission (ABDM) aims to replicate this success in healthcare delivery by building an equitable, accessible and inclusive ecosystem
First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
Subscribe To Our Newsletter & Stay Updated